Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review ; day:4 ; month:12 ; year:2024 ; pages:1-24
Clinical autonomic research ; (4.12.2024), 1-24
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Galli, Silvia
De Carolis, Lanfranco
Bianchini, Edoardo
Alborghetti, Marika
Caliò, Bianca
Pacilio, Pierre
Fanciulli, Alessandra
Pontieri, Francesco E.
Rinaldi, Domiziana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10286-024-01090-9
- URN
-
urn:nbn:de:101:1-2502182121304.880275441456
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Galli, Silvia
- De Carolis, Lanfranco
- Bianchini, Edoardo
- Alborghetti, Marika
- Caliò, Bianca
- Pacilio, Pierre
- Fanciulli, Alessandra
- Pontieri, Francesco E.
- Rinaldi, Domiziana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson’s Disease
PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease